Neurodegenerative Drugs Market

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.

Neurodegenerative Drugs Market contains market size and forecasts of Neurodegenerative Drugs in global, including the following market information:

• Global Neurodegenerative Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Neurodegenerative Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Neurodegenerative Drugs companies in 2021 (%)

The global Neurodegenerative Drugs market was valued at 118360 million in 2021 and is projected to reach US$ 174250 million by 2028, at a CAGR of 5.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

NMDA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurodegenerative Drugs include Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Neurodegenerative Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurodegenerative Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurodegenerative Drugs Market Segment Percentages, by Type, 2021 (%)

• NMDA
• SSRIs
• Dopamine Inhibitors

Global Neurodegenerative Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurodegenerative Drugs Market Segment Percentages, by Application, 2021 (%)

• Parkinson s Disease
• Huntington Disease
• Amyotrophic Lateral Sclerosis
• Alzheimer s Disease

Global Neurodegenerative Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurodegenerative Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Neurodegenerative Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Neurodegenerative Drugs revenues share in global market, 2021 (%)
• Key companies Neurodegenerative Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Neurodegenerative Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• Merck Serono
• Biogen Idec
• TEVA
• UCB
• Boehringer Ingelheim
• Sanofi
• GlaxoSmithKline
• Livzon Pharmaceutical
• Haisco Pharmaceutical
• Jingxin Pharmaceutical
• Dongcheng Biochemicals
• Hisun Pharmaceutical
• Luye Pharma
• Ark Pharmaceutical
• Kanghong Pharmaceutical
• Huahai Pharmaceutical
• BORA PHARMACEUTICALS